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In West Africa, India, and certain regions of Europe, both human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2)
are known to cocirculate. To investigate the HIV-1 subtypes involved in dual HIV-1 and HIV-2 infections, we sequenced the
envelope C2–V3 region from 29 dually infected female commercial sex workers from Senegal. The majority of women (23 of
29) were infected by HIV-1 subtype A. Within the HIV-1 subtype A sequences, 14 of 23 (60.8%) clustered with the West African
associated A/G recombinant form (IbNG), and 9 of 23 (39.2%) formed a separate cluster distinct from the A/G IbNG. In
contrast, in HIV-1 singly infected individuals, non-IbNG subtype A was found in only 13 of 98 (13.3%). Therefore, the lack of
protection and/or interaction with HIV-2 was associated with a distinct HIV-1 A genotype. These results suggest differences
in the biological properties of HIV-1 genotypes and their in vivo interaction with HIV-2. © 2000 Academic Press
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Genetic variability is a hallmark of the human immu-
nodeficiency virus (HIV); this characteristic also affects
the epidemiology and diagnosis of HIV infection. The
high mutation rate and the frequency of genetic recom-
bination combined give retroviruses the capacity to rap-
idly evolve while retaining their biological characteristics
with regard to transmission, infection of target cells, and
pathogenic potential to their hosts. As of December 1998,
the Joint United Nations Program on HIV/AIDS (UNAIDS)
estimated that there was a cumulative total of 34 million
cases of HIV infections; 62% of these cases have oc-
curred in sub-Saharan Africa, where more than 70% of
these infections are due to heterosexual transmission.
The genetic classification system of HIV-1 subtypes is
a consequence of the clustering patterns formed when
viral sequences are organized through phylogenetic
analysis into associated lineages. Phylogenetic analysis
of nucleotide sequences of HIV-1 has led to the definition
of three groups: M (major), O (outlier), and N (non-M/non-
O). Within the M group, at least 10 HIV-1 subtypes (A–J)
have been described (Burke and McCutchan, 1997).
HIV-1 group M viruses are largely responsible for the
AIDS pandemic and are spreading worldwide, whereas
group O viruses are rarely isolated and almost never
found outside the western part of equatorial Africa
(Gurtler et al., 1996). The newly described N group is
probably the least widespread HIV-1 lineage (Simon et1 To whom reprint requests should be addressed.
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402al., 1998); it has been documented in only two individuals
from Cameroon.
The genetic diversity of HIV-2 is less extensive, and
only two subtypes (A and B) have been well character-
ized. Other studies have reported the existence of four
additional subtypes (C–F), but attempts to isolate these
newly identified subtypes have so far met with little
success (Chen et al., 1997; Gao et al., 1994; Heredia et
al., 1997). Currently, HIV-2 subtype A is the best charac-
terized and appears to be the major subtype circulating
in West Africa (Norrgren et al., 1997; Peeters et al., 1998;
Sankale et al., 1995; Xiang et al., 1997). As with HIV-1, the
potential impact on epidemiology, pathogenicity, and
transmission of these newly described subtypes (A–F) is
not well understood.
Most of the 10 known HIV-1 subtypes have been re-
ported in sub-Saharan Africa, although their distribution
varies by locale, with multiple subtypes cocirculating in
many areas. The HIV-1 genetic subtype A is the most
prevalent in Africa. In addition to its wide geographic
range, it has a much greater diversity within subtypes
than other subtypes (Asjo et al., 1997; Burke and Mc-
Cutchan, 1997; Sankale et al., 1999). The immunological
relevance of genetic diversity and its impact on HIV-1
vaccine efficacy are poorly understood. Furthermore, a
number of recent studies have suggested an association
between HIV-1 subtypes and geographic distribution,
mode of transmission, and disease outcome (Harmelen
et al., 1997; Kanki et al., 1999; Neilson et al., 1999; Soto-
Ramirez et al., 1996; Tscherning et al., 1998).In West Africa, HIV-1 and HIV-2 coinfection or super-
infection has been reported, and our understanding of
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403HIV-2 INTERACTION PREDICTS HIV-1 GENOTYPEthe immunobiology and molecular epidemiology of these
dual infections has improved substantially in recent
years (Ariyoshi et al., 1998; Dieng Sarr et al., 1998, 1999).
Data from a prospective follow-up of sex workers from
the Dakar cohort have shown that prior infection with
HIV-2 confers natural protection against subsequent
HIV-1 infection (Travers et al., 1995), and this finding has
been confirmed in an updated analysis extending 13
years (Travers et al., unpublished data). Although the
mechanism underlying this natural protection is still not
fully understood, different virologic and immunological
studies have shown results that support these epidemi-
ological data (Akimoto et al., 1998; Arya and Gallo, 1996;
Kaneko et al., 1997; Martin and Nayak, 1996; Sekigawa et
al., 1998).
In this study, we characterized HIV-1 genotype distri-
bution among subjects who were dually infected with
HIV-1 and HIV-2 and evaluated potential associations
between different HIV-1 subtypes during dual infection.
To date, no studies have been performed to evaluate
HIV-1 or HIV-2 genotype diversity within dually infected
subjects, and such information may identify viral deter-
minants involved in this interaction.
RESULTS
Uncultured peripheral blood mononuclear cells (PB-
MCs) from 29 HIV-1 and HIV-2 dually infected female
commercial sex workers, all confirmed with both provi-
ruses by PCR analysis, were included in this study
(Dieng Sarr et al., 1998). HIV-1 subtypes were determined
by PCR and cloning of the C2–V3 region of the HIV-1
glycoprotein envelope as previously described (Kanki et
al., 1999). In this population, 17 were Senegalese, 11
were Ghanaian, and 1 was Nigerian. The status and
sequential order of infection are summarized in Table 1.
The majority, 23 of 29 (79.3%) individuals, were in-
fected by viruses belonging to HIV-1 subtype A sup-
ported by a high bootstrap value of 77%. One virus was
found to be an A/G recombinant in the env region studied
using recombination identification program analysis
(Siepel et al., 1995), whereas the remaining viruses be-
longed to subtypes D (three), C (one), G (one), and J
(one). One subject was found to be infected with two
different HIV-1 subtypes (A and D) (Fig 1). The 23 subtype
A viruses segregated in two distinct groups (Fig 1). The
first group of subtype A sequences clustered together
with three A/G reference sequences: IbNG, DJ263A, and
DJ264A (14 of 23, 60.8%). This group of genotype A
viruses has been shown to belong to genotype A in the
region of the genome studied and A/G recombinant in
other regions (McCutchan et al., 1999). This cluster of
viruses is found primarily in West Africa, with a few
reference viruses described in Djibouti as exceptions
(Asjo et al., 1997; Janssens et al., 1997; Louwagie et al.,
f
s995; McCutchan et al., 1999; Carr et al., 1999). A second
onophyletic group of genotype A sequences (9 of 23,
9.2%) was more homogeneous and clustered with a
igh bootstrap value (87.4%). The three subtype D se-
uences branched with the reference D strains NdK and
4UG114 with an 88% bootstrap value. The J genotype
lustered with reference strains SE92809 and SE91733;
his branch was supported by 94.5% of the bootstrap
eplicates.
The amino acid translation of the V3 loop from all the
nalyzed nucleotide sequences revealed that the GPGQ
etrameric amino acid motif at the tip of the V3 loop was
resent in 29 of 30 (96.6%) of the sequences; only the A/G
ecombinant virus was found to have a GPGR motif. The
ajority of the sequences were composed of 35 amino
cids; the three subtype D sequences had 34 amino
cids in the V3 due to a deletion of a glycine (G) at
osition 24. The subtype D (2 of 3) and the J subtype
ere the only strains with a positively charged amino
cid [lysine (K) or histidine (H) for J subtype] at position
5 in the V3 instead of a neutral or negatively charged
mino acid found in the majority of the sequences. We
nvestigated whether there were any amino acid patterns
n the V3 loop that could differentiate the two groups
bserved within subtype A. Most sequences from the
econd group (SC-2 in Fig. 1) encoded a histidine (H)
nstead of an arginine (R) at position 13 and an alanine
A) instead of a threonine (T) at position 19 (Table 2).
hese amino acid changes did not affect the overall
harge of the loop, although they are part of a signature
equence that has been identified as being responsible
TABLE 1
Characteristics of HIV-1 and HIV-2 Dually Infected Women
Serohistory
na 3.3b 0.3c 0.1.3d 1.3e 0.2.3 f 2.3g
Senegal 17 9 2 1 0 2 3
Subtype A 13 5 2 1 0 2 3
Ghana 11 9 0 0 1 0 1
Subtype A 10 8 0 0 1 0 1
Nigeria 1 0 0 0 1 0 0
Subtype A 1 0 0 0 1 0 0
Total 29 18 2 1 2 2 4
Subtype A 24 13 2 1 2 2 4
a n, number of samples.
b 3.3, seroprevalent HIV-Dual.
c 0.3, seronegative at entry and later seroconverted to HIV-Dual.
d 0.1.3, seronegative at entry, seroconverted to HIV-1, and later con-
verted to HIV-Dual.
e 1.3, seroprevalent HIV-1 at entry and later converted to HIV-Dual.
f 0.2.3, seronegative at entry, seroconverted to HIV-2, and later con-
erted to HIV-Dual.
g 2.3, seroprevalent HIV-2 at entry and later converted to HIV-Dual.or the misidentification of subtype A as subtype C in
erological subtyping assays (Plantier et al., 1999).
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404 SARR ET AL.DISCUSSION
In this study, we report the HIV-1 subtype distribution
mong HIV-1 and HIV-2 dually infected female commer-
ial sex workers in Senegal. Because of their status as
ually infected and the lack of data addressing the roles
f HIV-1 and HIV-2 genotypes associated with dual in-
ection, we chose to analyze HIV-1 strain circulation in
his unique population.
Our results have shown that the HIV-1 subtype A is
redominant in this population and accounts for 79.3% of
FIG. 1. Phylogenetic analysis by neighbor joining method of C2–V3 en
infected). Representative C2–V3 envelope sequences of various HIV-
resamplings; number of resamplings is indicated at major branch points
within subtype A. *Individual with subtype (A and D) coinfection. §A/Ghe circulating viruses. These results are in agreement
ith previous studies in the same cohort that have re-
1orted a majority of genotype A in singly HIV-1-infected
ubjects (Kanki et al., 1999). We found that there were no
ifferences in subtype distribution according to age, year
f infection, or duration of prostitution. There also was no
ifference according to nationality or order of infection
Table 1). This report is the first description of HIV-1
ubtype J in Senegal. Few studies have reported data on
his newly characterized subtype, and current sequences
re available only from patients originating from the
emocratic Republic of Congo (Zaire) (Laukkanen et al.,
sequences from registered female sex workers (HIV-1 and HIV-2 dually
pes A–J are underlined. Alignment was subjected to 1000 bootstrap
bNG subcluster and subcluster 2 delineate the two distinct subclusters
inant. The scale bar represents 2% nucleotide sequence divergence.velope
1 subty999).
We also found in this study that one Senegalese sub-
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405HIV-2 INTERACTION PREDICTS HIV-1 GENOTYPEject was infected with two different subtypes of HIV-1 (A
and D) as well as with HIV-2 genotype A (data not
shown). This observation demonstrates that infection
with more than two phylogenetically distinct viruses is
possible: in this case, triple infection with HIV-1 subtypes
A and D and HIV-2 subtype A. A similar observation has
also been reported in a Cameroonian woman infected
with subtypes A and D and HIV-1 group O (Takehisa et
l., 1997). Based on the envelope region evaluated, we
ould not find evidence of recombination; however, full
enome sequencing would be required to fully address
his possibility. It has been suggested that recombinant
iruses account for approximately 10% of all HIV-1 iso-
ates (Cornelisen et al., 1996; Robertson et al., 1995), and
ecombination is predicted to occur when there is coin-
ection of a cell by highly related retroviruses. This case
ay be a unique opportunity to study how HIV-1 inter-
ubtype recombination might be generated in vivo.
In dually infected individuals, the subtype A se-
uences were heterogeneous with a pairwise diversity
f 13.43 6 2.94%. We also noted the presence of two
istinct subclusters within the subtype A branch. Four-
een of 23 (60.8%) A genotypes grouped with the three
/G reference sequences IbNG, DJ263A, and DJ264A.
he A/G IbNG subcluster had a pairwise diversity of
T
HIV-1 A, V3 Am
1
CONS A CTRPNNNTRKSV
dd697 ....G......I
dda472 ....G..K.T.I
ddb557 ....G....Q..
ddb357 ....G.......
dda721 ....G....R.M
dd964 .I..........
dda761 ............
ddd974 ....A.......
dd922 ............
dd520 ............
dd962 ............
dda376 ............
dd946 ............
ddc76 .I..Y......I
dd754 ...L....G...
dd743 ...H..H...G.
dd749 ............
ddb410 ..........G.
dd935 ............
ddb85 ............
ddb252 ............
dde303 ....H....R..
ddb501 .........RG.
Note. V3 amino acids from the two distinct subclusters A/G lbNG a2.24 6 1.95% and was more heterogeneous than the
econd subcluster. Such diversity might be related to the
T
vresence of older strains or multiple entries of different
ariants in this population. The second subcluster (SC-2)
epresented 39.2% (9 of 23) of the subtype A sequences
nalyzed, forming a distinct subcluster from the A/G
bNG-like sequences with a high bootstrap value 87.4%.
e also sequenced a subset of viruses from the non-
bNG subcluster in the Gag region (39 p24/59 p7), and we
onfirmed that they formed a distinct cluster (data not
hown). This group of viruses was more homogeneous
ith a pairwise diversity of 8.65 6 2.13%. The difference
n diversity between these two subclusters of A geno-
ypes was statistically significant (Student’s t test; P 5
.0004). The lower level of diversity in the non-IbNG
roup of viruses might be related to a founder effect due
o a single variant circulating in this population or a
ecent introduction of this genotype A. We further inves-
igated whether this subtype A variant was present in the
ingly HIV-1-infected individuals from that same cohort
nd found this variant was underrepresented in incident
IV-1 infection (7 of 46, 15.22%) (Kanki et al., 1999) as well
s seroprevalent HIV-1 infection (6 of 52, 11.6%) (Hamel et
l., unpublished data). Thus these variants of genotype A
SC-2) were present at a higher level in the dually in-
ected population than in the population of singly in-
ected individuals (Fisher’s exact test, P 5 0.007) (Fig. 2).
id Translation
19
QAFYATGDIIGDIRQAHC
.T.....G..........
.T......VV......Y.
.T...Y..V.........
.T.......T........
.T................
.T.........N......
.T................
.TY...........R... A/G IbNG
.T................ subcluster
.T.S.......N......
.T................
.T....-N..........
.T.....E..........
..................
..............K...
...........N..K...
..................
...........N......
.......N........Y. subcluster 2
..............R.Y.
...........N......
.V............R.Q.
.V.........N......
. Amino acid positions 13 and 19 are boxed.ABLE 2
ino Ac
3
RIGPG
.....
.....
S....
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
H....
H....
P....
H....
H....
H....
H....
.....
HL...his putative association between dual infection and the
ariant A subcluster (SC-2) might result from a selective
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407HIV-2 INTERACTION PREDICTS HIV-1 GENOTYPEadvantage driven by coinfection or prior infection with
HIV-2. However, this possibility would be difficult to con-
firm because we do not know the order of infection in all
of our dual infections. The epidemiology of HIV-1 and
HIV-2 infection in West Africa suggests that it is unlikely
that the majority of the subjects were infected with HIV-1
first because HIV-2 is endemic and HIV-1 has only re-
cently entered the population (Kanki, 1997).
Viral phenotypes play an important role in transmis-
sion, replication competence, and disease progression
(De wolf et al., 1994; Shankarappa et al., 1998). Previous
tudies have shown that the total positive charge of the
3 loop, as well as positively charged amino acids at
ositions 11 and/or 25 in the V3, may be an indicator of
n SI phenotype or CXCR4 use (Bhattacharyya et al.,
996; Fouchier et al., 1992; Peeters et al., 1999; Tschern-
ng et al., 1998), although studies to correlate sequence
rediction and in vitro phenotype have reported mixed
onclusions (Xiao et al., 1998).
In addition, HIV-2 gp 105 has been shown to specifi-
ally bind and stimulate CD81 cells, leading to an up-
egulation of b-chemokine production (Kaneko et al.,
997; Neoh et al., 1997; Sekigawa et al., 1998). Studies in
ur laboratory have confirmed the up-regulation of
b-chemokines in HIV-2-infected PBMCs (Kokkotou et al.,
submitted). Based on these data, we might anticipate
that during coinfection with HIV-2, such up-regulation of
b-chemokines might favor HIV-1 to shift away from CCR5
coreceptor utilization and that such a shift could be
predicted based on an amino acid signature pattern in
the V3 loop. More recent studies have shown that there
may be differences in chemokine coreceptor use be-
tween HIV-1 subtypes; subtype D was found to be un-
usual in its exclusive use of CXCR4 (Tscherning et al.,
998). Considering these data, we studied the amino
cid translation of the V3 loop as well as the presence of
ositively charged amino acids at specific positions (11
nd 25). We noted that two of three genotype D viruses
nd a genotype J virus were the only strains with a
ositively charged amino acid [lysine (K) or histidine (H)
or J subtype] at position 25 in the V3 loop (data not
hown). This position is predicted to be occupied by a
eutral or negatively charged amino acid in most CCR5-
sing viruses. Within the subtype A strains, the average
f charged amino acids in the V3 loop between the two
ubclusters was not significantly different between the
bNG subcluster and SC-2 (4.2 versus 4.6), and both of
heir amino acid patterns suggested CCR5 coreceptor
se. These results imply that coinfection with HIV-2
FIG. 2. Phylogenetic analysis by neighbor joining method of C2–V3 e
HIV-1 and HIV-2 and representative sequences from singly infected HIV
indicated. Alignment was subjected to 1000 bootstrap resamplings. Va
subcluster and subcluster 2 delineate the two distinct subclusters of sequence
individuals. The scale bar represents 2% nucleotide sequence divergence. Thmight not affect HIV-1 coreceptor use. However, due to
the mixed results reported between predicted viral phe-
notype and in vitro phenotype, these results should be
considered with caution. An evaluation of the clinical
status of the subjects associated with in vitro coreceptor
analysis would be useful to further address this question.
We also noted that SC-2 of subtype A viruses encoded
a histidine (H) instead of an arginine (R) at position 13
and an alanine (A) instead of a threonine (T) at position
19, although these amino acid changes did not affect the
overall charge of the loop. These positions are part of a
three-amino-acid signature that has been shown to be
critical in the correct serological diagnostic of subtype A.
Due to phenetic similarity, sera from a significant propor-
tion of subtype A-infected individuals are reactive with
subtype C V3 peptides when assayed in serological
subtyping assays. We recently showed that these three
residues were associated with this cross-reactivity (Plan-
tier et al., 1999); an arginine/histidine substitution at
position 13 and a threonine/alanine substitution at posi-
tion 19 of the loop are two of these. We also showed that
most subtype A viruses from Senegal-induced antibod-
ies reactive primarily to the C peptide. These results
would predict that sera from subjects with sequences
from the A/G IbNG subcluster would be reactive primarily
with the C peptide and subjects from SC-2 with the A
peptide, and our serology evaluation supports this hy-
pothesis (data not shown). It remains to be determined to
what extent these amino acid changes are further related
to biological or serological differences between sub-
types.
Our study describes the distribution of HIV-1 geno-
types among a population of HIV-1 and HIV-2 dually
infected female commercial sex workers in Senegal. The
overall phylogenetic analysis of strains circulating in this
population based on the nucleotide sequences of the
env region C2–V3 indicates the predominance of the A
genotype, although subtypes C, D, A/G, and J were also
present. These results are in agreement with previous
studies in Senegal and other West African countries that
have addressed HIV-1 genotypes diversity among HIV-1-
infected subjects (Kanki et al., 1999; McCutchan et al.,
999). However, it is important to mention that certain
ubtle trends were found; two subclusters within subtype
were identified. We do not know to what extent this
ubcluster of non-A/G IbNG-like viruses may affect the
atural history of dual infection. However, a more exten-
ive study of this non-IbNG subcluster by characteriza-
ion of full-length sequence of the viral envelope or ge-
e sequences from registered female sex workers dually infected with
iduals. Envelope sequences of various HIV-1 subtype A references are
the nodes of the tree are percentages of 1000 bootstraps. A/G IbNGnvelop
-1 indiv
lues ats within subtype A. Black dots indicate HIV-1 and HIV-2 dually infected
e tree was truncated by removing non-subtype A branches.
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408 SARR ET AL.nome might lead to a better understanding of its patho-
genesis. We have shown in a recent study that HIV-2
sequences from the same population of dual HIV-1- and
HIV-2-infected persons were all subtype A. In addition,
no specific sequence differences or genetic clustering
was observed when comparing HIV-2 sequences from
dually infected and HIV-2 singly infected in the same
cohort, suggesting that HIV-2 subtype is not a significant
determinant in the outcome of dual infection (Dieng Sarr
et al., 1999). Further investigation of these differences
within subtype A viruses and more sequence information
from neighboring countries affected by HIV-1 and HIV-2
infection may be central to the understanding of HIV-1
and HIV-2 interactions and dual infection.
Most importantly, our results demonstrate that the in
vivo interaction between HIV-1 and HIV-2 is modulated at
he level of the HIV-1 genotype. The prevalence of the
on-IbNG genotype A was significantly higher in the
ually infected women (9 of 23, 39.2%) compared with
omen who were singly infected with HIV-1 (13 of 98,
3.3%). It is possible that the mechanisms of HIV-2 pro-
ection may be less efficacious with this genotype of
IV-1 compared with the more common West African
enotype A (IbNG). This result also suggests that genetic
iversity, even at a level of viral genotype, may be a
ritical determinant in immune protection. Further stud-
es of the biological properties of these genetically de-
ined viruses will be important to our understanding of
orrelates of protection and their relevance for HIV vac-
ine design.
MATERIALS AND METHODS
This study is part of an ongoing prospective clinical
cohort of female commercial sex workers in Dakar,
Senegal. We previously reported on various epidemio-
logical and clinical aspects of this cohort (Kanki et al.,
1994). All study participants gave informed consent be-
fore enrollment and sample collection. Sera were evalu-
ated for antibody reactivity to the major viral antigens of
HIV-1 and HIV-2 by immunoblotting. Samples showing
dual reactivity were confirmed with specific recombinant
peptides from the envelope glycoproteins of HIV-1 and
HIV-2 (Gueye-Ndiaye et al., 1993). All samples fitting the
serological criteria for a dual profile were then subjected
to HIV-1 and HIV-2 proviral DNA PCR using nested
primer pairs for gag and env of both HIV-1 and HIV-2
viruses, as previously described (Dieng Sarr et al., 1998).
Sample collection and DNA extraction
Peripheral blood was drawn into EDTA tubes, and
PBMCs were separated with Ficoll-Hypaque. DNA was
extracted from frozen PBMCs by proteinase K–phenol
extraction. Briefly, the cells were washed in PBS, resus-
pended, and incubated in sodium chloride-Tris-EDTA/
SDS (0.5%)/proteinase K (100 mg/ml) at 56°C for 12 h. Thecell lysate was then subjected to four successive phe-
nol–chloroform extractions and ethanol precipitation.
The DNA was resuspended in Tris-EDTA, and the con-
centration was determined by measuring the optical den-
sity at 260 nm; one microgram was used for each PCR.
Amplification
The HIV-1 C2–V3 env region was amplified by nested
PCR using two sets of primers: WT1–WT2 for the first
round and KK30–KK40 for the second round. The condi-
tions for the nested PCR and the set of primers for PCR
amplification have been described elsewhere (Kanki et
al., 1999).
Cloning and sequencing
The PCR product was purified by agarose gel electro-
phoresis and purification columns (Qiaquick gel extrac-
tion kit; Quiagen Inc., Chatsworth, CA). The purified prod-
uct was cloned in PCR2.1 vector (T/A cloning; InVitrogen,
San Diego, CA). Positive colonies were chosen based on
X-Gal metabolism or after PCR screening. Plasmid prep-
aration for double-stranded DNA sequencing was per-
formed by alkaline lysis, using DEAE columns (plasmid
minikit; Qiagen Inc., Chatsworth, CA). Sequences were
determined for both DNA strands by dye terminator cycle
sequencing using Taq polymerase (Perkin–Elmer, Ap-
plied Biosystem Division, Foster City, CA) and an auto-
matic sequencer ABI 373 (Perkin–Elmer, Applied Biosys-
tem Division). In all cases, two or more clones were
sequenced per sample.
Sequence analysis and statistical methods
Multiple alignment of all generated sequence and ref-
erence sequences from the HIV database was per-
formed with the Clustal package (Clustal X) with minor
manual adjustment when necessary (Thompson et al.,
1997). Phylogenetic analysis was performed by the
neighbor-joining method and reliability estimated by
1000 bootstrap resamplings with complete removal of
positions that contained gaps using Clustal X and cor-
rection for multiple substitutions. Subtype assignment
was established based on phylogenetic clustering with
reference sequences supported by bootstraps values
above 75%. Distance analysis (p distance) was per-
formed using MEGA (Pennsylvania State University).
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